For: | Tsai CC, Chuang TW, Chen LJ, Niu HS, Chung KM, Cheng JT, Lin KC. Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells. World J Gastroenterol 2015; 21(14): 4169-4177 [PMID: 25892866 DOI: 10.3748/wjg.v21.i14.4169] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i14/4169.htm |
Number | Citing Articles |
1 |
|
2 |
Maryam Fallah, Amirhossein Davoodvandi, Shahin Nikmanzar, Sarehnaz Aghili, Seyed Mohammad Ali Mirazimi, Michael Aschner, Amir Rashidian, Michael R. Hamblin, Mohsen Chamanara, Navid Naghsh, Hamed Mirzaei. Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer. Biomedicine & Pharmacotherapy 2021; 142: 112024 doi: 10.1016/j.biopha.2021.112024
|
3 |
Shoeb Ikhlas, Masood Ahmad. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways. Life Sciences 2017; 185: 53 doi: 10.1016/j.lfs.2017.07.029
|
4 |
Muhamad Noor Alfarizal Kamarudin, Md. Moklesur Rahman Sarker, Jin-Rong Zhou, Ishwar Parhar. Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1495-2
|
5 |
Zahra Rezaei Harandi, Razieh Heidari, Somayeh Reiisi. Co-Delivery of Silymarin and Metformin Dual-Loaded in Mesoporous Silica Nanoparticles Synergistically Sensitizes Breast Cancer Cell Line to Mitoxantrone Chemotherapy. IEEE Transactions on NanoBioscience 2023; 22(4): 872 doi: 10.1109/TNB.2023.3242912
|
6 |
Akanksha Esmeeta, Subhamay Adhikary, V. Dharshnaa, P. Swarnamughi, Z. Ummul Maqsummiya, Antara Banerjee, Surajit Pathak, Asim K. Duttaroy. Plant-derived bioactive compounds in colon cancer treatment: An updated review. Biomedicine & Pharmacotherapy 2022; 153: 113384 doi: 10.1016/j.biopha.2022.113384
|
7 |
Mohammad‐Javad Sanaei, Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri‐Sigaroodi, Shabnam Shahrokh, Mohammad Reza Zali, Davood Bashash. The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles. Journal of Cellular Physiology 2022; 237(3): 1720 doi: 10.1002/jcp.30655
|
8 |
Saúl Redondo-Blanco, Javier Fernández, Ignacio Gutiérrez-del-Río, Claudio J. Villar, Felipe Lombó. New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00109
|
9 |
Alok Nath Sharma, Hitesh Kumar Dewangan, Prabhat Kumar Upadhyay. Comprehensive Review on Herbal Medicine: Emphasis on Current Therapy and Role of Phytoconstituents for Cancer Treatment. Chemistry & Biodiversity 2024; 21(3) doi: 10.1002/cbdv.202301468
|
10 |
Dominique Reed, Komal Raina, Rajesh Agarwal. Natural Products for Cancer Chemoprevention. 2020; : 161 doi: 10.1007/978-3-030-39855-2_6
|
11 |
Francesca Luca, Sonia S. Kupfer, Dan Knights, Alexander Khoruts, Ran Blekhman. Functional Genomics of Host–Microbiome Interactions in Humans. Trends in Genetics 2018; 34(1): 30 doi: 10.1016/j.tig.2017.10.001
|
12 |
Nagarjuna Reddy Desam, Abdul Jabbar Al-Rajab. Herbal Biomolecules in Healthcare Applications. 2022; : 435 doi: 10.1016/B978-0-323-85852-6.00001-9
|
13 |
Bahare Salehi, Patrick Valere Tsouh Fokou, Lauve Rachel Tchokouaha Yamthe, Brice Tchatat Tali, Charles Oluwaseun Adetunji, Amirhossein Rahavian, Fhatuwani Nixwell Mudau, Miquel Martorell, William N. Setzer, Célia F. Rodrigues, Natália Martins, William C. Cho, Javad Sharifi-Rad. Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic Agents. Nutrients 2019; 11(7): 1483 doi: 10.3390/nu11071483
|
14 |
Ye Li, Shu-Xiang Cui, Shi-Yue Sun, Wen-Na Shi, Zhi-Yu Song, Shu-Qing Wang, Xin-Feng Yu, Zu-Hua Gao, Xian-Jun Qu. Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin inAPCMin/+mice. Oncotarget 2016; 7(37): 60446 doi: 10.18632/oncotarget.11108
|
15 |
Navina Panneerselvan, Rajeswari Ravindran, Palanisamy Arulselvan, Ravindran Jaganathan. Anticancer Plants: Mechanisms and Molecular Interactions. 2018; : 43 doi: 10.1007/978-981-10-8417-1_3
|
16 |
Shailaja Dombe, Pramodkumar Shirote. Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review. Current Drug Targets 2021; 22(4): 443 doi: 10.2174/1389450121999201012201455
|
17 |
Balaji Chandrasekaran, Deeksha Pal, Venkatesh Kolluru, Ashish Tyagi, Becca Baby, Nisha R Dahiya, Khafateh Youssef, Houda Alatassi, Murali K Ankem, Arun K Sharma, Chendil Damodaran. The chemopreventive effect of withaferin A on spontaneous and inflammation-associated colon carcinogenesis models. Carcinogenesis 2018; 39(12): 1537 doi: 10.1093/carcin/bgy109
|
18 |
Mohammad rafi Khezri, Hassan Malekinejad, Naime Majidi-Zolbanin, Morteza Ghasemnejad-Berenji. Anticancer potential of metformin: focusing on gastrointestinal cancers. Cancer Chemotherapy and Pharmacology 2021; 87(5): 587 doi: 10.1007/s00280-021-04256-8
|
19 |
Jun Gong, Gauri Kelekar, James Shen, John Shen, Sukhpreet Kaur, Monica Mita. The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development. Targeted Oncology 2016; 11(4): 447 doi: 10.1007/s11523-016-0423-z
|
20 |
Zohreh Jahanafrooz, Nasrin Motamed, Beate Rinner, Ahad Mokhtarzadeh, Behzad Baradaran. Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator. Life Sciences 2018; 213: 236 doi: 10.1016/j.lfs.2018.10.009
|
21 |
Javed Iqbal, Banzeer Ahsan Abbasi, Tariq Mahmood, Sobia Kanwal, Barkat Ali, Sayed Afzal Shah, Ali Talha Khalil. Plant-derived anticancer agents: A green anticancer approach. Asian Pacific Journal of Tropical Biomedicine 2017; 7(12): 1129 doi: 10.1016/j.apjtb.2017.10.016
|
22 |
Soumaye Amirsaadat, Davoud Jafari-Gharabaghlou, Sepideh Alijani, Hanieh Mousazadeh, Mehdi Dadashpour, Nosratollah Zarghami. Metformin and Silibinin co-loaded PLGA-PEG nanoparticles for effective combination therapy against human breast cancer cells. Journal of Drug Delivery Science and Technology 2021; 61: 102107 doi: 10.1016/j.jddst.2020.102107
|
23 |
Mohammad Arif Ashraf, Mohammad Nazim. Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature’s Bounty. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/8602879
|
24 |
Mehdi Koushki, Reyhaneh Farrokhi Yekta, Nasrin Amiri-Dashatan. Critical review of therapeutic potential of silymarin in cancer: A bioactive polyphenolic flavonoid. Journal of Functional Foods 2023; 104: 105502 doi: 10.1016/j.jff.2023.105502
|
25 |
Manrose Singh, Akito T. Nicol, Jaclyn DelPozzo, Jia Wei, Mandeep Singh, Tony Nguyen, Satoru Kobayashi, Qiangrong Liang. Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.839644
|
26 |
Mei-Jia Zhang, Han Su, Jing-Yue Yan, Na Li, Zhi-Yu Song, Huai-Jie Wang, Lian-Guang Huo, Feng Wang, Wan-Sheng Ji, Xian-Jun Qu, Mei-Hua Qu. Chemopreventive effect of Myricetin, a natural occurring compound, on colonic chronic inflammation and inflammation-driven tumorigenesis in mice. Biomedicine & Pharmacotherapy 2018; 97: 1131 doi: 10.1016/j.biopha.2017.11.018
|
27 |
Kalpana Tilekar, Neha Upadhyay, Cristina V. Iancu, Vadim Pokrovsky, Jun-yong Choe, C.S. Ramaa. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188457 doi: 10.1016/j.bbcan.2020.188457
|
28 |
Elnaz Salmani-Javan, Davoud Jafari-Gharabaghlou, Esat Bonabi, Nosratollah Zarghami. Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1193708
|
29 |
Kübra Demir, Rana Turgut, Selcen Şentürk, Handan Işıklar, Elif Günalan. The Therapeutic Effects of Bioactive Compounds on Colorectal Cancer via PI3K/Akt/mTOR Signaling Pathway: A Critical Review. Food Science & Nutrition 2024; 12(12): 9951 doi: 10.1002/fsn3.4534
|
30 |
Jing Sang, Ruixue Tang, Min Yang, Qing Sun, Luenda Charles. Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5‐FU. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/9312149
|
31 |
Sadia Afrin, Francesca Giampieri, Massimiliano Gasparrini, Tamara Y. Forbes-Hernández, Danila Cianciosi, Patricia Reboredo-Rodriguez, Jiaojiao Zhang, Piera Pia Manna, Maria Daglia, Atanas Georgiev Atanasov, Maurizio Battino. Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved. Biotechnology Advances 2020; 38: 107322 doi: 10.1016/j.biotechadv.2018.11.011
|
32 |
Nitin R. Shirsath, Ajaygiri K. Goswami. Natural Phytochemicals and Their Therapeutic Role in Management of Several Diseases: A Review. Current Traditional Medicine 2020; 6(1): 43 doi: 10.2174/2215083805666190807111817
|
33 |
Linh N.K. Tran, Ganessan Kichenadasse, Lisa M. Butler, Margaret M. Centenera, Katherine L. Morel, Rebecca J. Ormsby, Michael Z. Michael, Karen M. Lower, Pamela J. Sykes. The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer. Molecular Cancer Therapeutics 2017; 16(12): 2689 doi: 10.1158/1535-7163.MCT-17-0074
|
34 |
Yu-De Chu, Chun-Wei Chen, Ming-Wei Lai, Siew-Na Lim, Wey-Ran Lin. Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly. World Journal of Gastroenterology 2023; 29(29): 4499-4527 doi: 10.3748/wjg.v29.i29.4499
Abstract(649) |
Core Tip(638) |
Full Article(HTML)(2747)
|
Full Article with Cover (PDF)-5713K(166)
|
Full Article (Word)-3415K(37)
|
Audio-144K(5)
|
Peer-Review Report-265K(57)
|
Answering Reviewers-282K(63)
|
Full Article (PDF)-5295K(218)
|
Full Article (XML)-586K(61)
|
Times Cited (4)
|
Total Visits (7422)
|
Open
|
35 |
Meghanath B. Shete, Ashwini S. Deshpande, Pravin Shende. Silybin-based herbal nanocarriers: an advancement in anticancer therapy. Materials Technology 2022; 37(13): 2832 doi: 10.1080/10667857.2022.2081286
|
36 |
Joaquim Bosch-Barrera, Bernardo Queralt, Javier A. Menendez. Targeting STAT3 with silibinin to improve cancer therapeutics. Cancer Treatment Reviews 2017; 58: 61 doi: 10.1016/j.ctrv.2017.06.003
|